[96a5a0]: / output / allTrials / identified / NCT02783794_identified.json

Download this file

641 lines (641 with data), 27.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
{
"info": {
"nct_id": "NCT02783794",
"official_title": "A Randomized, Double Blind and Placebo Controlled Multicenter Study Comparing BP-C1 and Equal Looking Placebo in Metastatic Breast Cancer Patients. A Phase IIB Study",
"inclusion_criteria": "Female patients with histologically verified metastatic breast cancer (stage IV) with measurable metastases, between 18 and 80 years of age, who had undergone at least three lines of chemotherapy and had an expected survival time of at least 3 months.\n\nExclusion criteria:\n\nPatients fulfilling at least one of the following criteria will be excluded from participation in the study:\n\n* Abnormal liver function classified as total bilirubin >34 μmol/L or ALAT > 3 times of the upper limit of normal (ULN). In case of metastases in the liver, the ALAT limit for exclusion is set to 5хULN.\n* Abnormal kidney function defined by serum creatinine >120 μmol/L.\n* Abnormal coagulation capacity defined by the relative arbitrary concentration of coagulation factors 2,7,10; INR >1.5.\n* Verified metastases to the brain.\n* Synchronous cancer except for non-melanoma skin cancer and early stage of cervical cancer.\n* Abnormal hematology status defined by hemoglobin < 9.0 g/dL, platelet count < 100,000/mm^3 or leucocytes < 3 x 10^9/L.\n* Clinically significant abnormal ECG.\n* Karnofsky performance status score <60%.\n* Pregnant or breast feeding women.\n* Women of fertile age who do not want to be tested for possible pregnancy.\n* Fertile female who do not want to use safe protection against pregnancy, starting one month before the start of the study treatment and lasting at least six weeks after.\n* Uncontrolled bacterial, viral, fungal or parasite infection.\n* Under systemic treatment with corticosteroids or other immunosuppressive drugs in the last 21 days before start of the trial treatment.\n* Participating in another clinical trial with pharmaceuticals in the last six weeks before start of this trial treatment.\n* Not able to understand information.\n* Not willing or not able to give written consent to participate in the study.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "Female patients with histologically verified metastatic breast cancer (stage IV) with measurable metastases, between 18 and 80 years of age, who had undergone at least three lines of chemotherapy and had an expected survival time of at least 3 months.",
"criterions": [
{
"exact_snippets": "Female patients",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "histologically verified metastatic breast cancer (stage IV)",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
},
{
"requirement_type": "verification",
"expected_value": "histologically verified"
}
]
},
{
"exact_snippets": "measurable metastases",
"criterion": "metastases",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": true
}
]
},
{
"exact_snippets": "between 18 and 80 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 80,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "undergone at least three lines of chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "lines",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "lines"
}
}
]
},
{
"exact_snippets": "expected survival time of at least 3 months",
"criterion": "expected survival time",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Abnormal liver function classified as total bilirubin >34 μmol/L or ALAT > 3 times of the upper limit of normal (ULN). In case of metastases in the liver, the ALAT limit for exclusion is set to 5хULN.",
"criterions": [
{
"exact_snippets": "Abnormal liver function classified as total bilirubin >34 μmol/L",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 34,
"unit": "μmol/L"
}
}
]
},
{
"exact_snippets": "Abnormal liver function classified as ... ALAT > 3 times of the upper limit of normal (ULN)",
"criterion": "ALAT",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "times ULN"
}
}
]
},
{
"exact_snippets": "In case of metastases in the liver, the ALAT limit for exclusion is set to 5хULN",
"criterion": "ALAT with liver metastases",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 5,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* Abnormal kidney function defined by serum creatinine >120 μmol/L.",
"criterions": [
{
"exact_snippets": "Abnormal kidney function defined by serum creatinine >120 μmol/L.",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 120,
"unit": "μmol/L"
}
}
]
}
]
},
{
"line": "* Abnormal coagulation capacity defined by the relative arbitrary concentration of coagulation factors 2,7,10; INR >1.5.",
"criterions": [
{
"exact_snippets": "Abnormal coagulation capacity defined by the relative arbitrary concentration of coagulation factors 2,7,10",
"criterion": "coagulation factors 2,7,10",
"requirements": [
{
"requirement_type": "concentration",
"expected_value": "abnormal"
}
]
},
{
"exact_snippets": "INR >1.5",
"criterion": "INR",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Verified metastases to the brain.",
"criterions": [
{
"exact_snippets": "Verified metastases to the brain",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "verification",
"expected_value": true
}
]
}
]
},
{
"line": "* Synchronous cancer except for non-melanoma skin cancer and early stage of cervical cancer.",
"criterions": [
{
"exact_snippets": "Synchronous cancer",
"criterion": "synchronous cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "non-melanoma skin cancer",
"criterion": "non-melanoma skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "early stage of cervical cancer",
"criterion": "early stage cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Abnormal hematology status defined by hemoglobin < 9.0 g/dL, platelet count < 100,000/mm^3 or leucocytes < 3 x 10^9/L.",
"criterions": [
{
"exact_snippets": "hemoglobin < 9.0 g/dL",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 9.0,
"unit": "g/dL"
}
}
]
},
{
"exact_snippets": "platelet count < 100,000/mm^3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": "<",
"value": 100000,
"unit": "mm^3"
}
}
]
},
{
"exact_snippets": "leucocytes < 3 x 10^9/L",
"criterion": "leucocyte count",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "x 10^9/L"
}
}
]
}
]
},
{
"line": "* Clinically significant abnormal ECG.",
"criterions": [
{
"exact_snippets": "Clinically significant abnormal ECG",
"criterion": "ECG",
"requirements": [
{
"requirement_type": "abnormality",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* Karnofsky performance status score <60%.",
"criterions": [
{
"exact_snippets": "Karnofsky performance status score <60%",
"criterion": "Karnofsky performance status score",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 60,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Pregnant or breast feeding women.",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast feeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Women of fertile age who do not want to be tested for possible pregnancy.",
"criterions": [
{
"exact_snippets": "Women of fertile age",
"criterion": "fertile age",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "do not want to be tested for possible pregnancy",
"criterion": "willingness to be tested for pregnancy",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": false
}
]
}
]
},
{
"line": "* Fertile female who do not want to use safe protection against pregnancy, starting one month before the start of the study treatment and lasting at least six weeks after.",
"criterions": [
{
"exact_snippets": "Fertile female",
"criterion": "fertility",
"requirements": [
{
"requirement_type": "fertility status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "do not want to use safe protection against pregnancy",
"criterion": "use of contraception",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": false
}
]
},
{
"exact_snippets": "starting one month before the start of the study treatment and lasting at least six weeks after",
"criterion": "duration of contraception use",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "one month before the start of the study treatment and lasting at least six weeks after"
}
]
}
]
},
{
"line": "* Uncontrolled bacterial, viral, fungal or parasite infection.",
"criterions": [
{
"exact_snippets": "Uncontrolled bacterial ... infection.",
"criterion": "bacterial infection",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "Uncontrolled ... viral ... infection.",
"criterion": "viral infection",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "Uncontrolled ... fungal ... infection.",
"criterion": "fungal infection",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "Uncontrolled ... parasite infection.",
"criterion": "parasite infection",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
}
]
},
{
"line": "* Under systemic treatment with corticosteroids or other immunosuppressive drugs in the last 21 days before start of the trial treatment.",
"criterions": [
{
"exact_snippets": "Under systemic treatment with corticosteroids",
"criterion": "systemic treatment with corticosteroids",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other immunosuppressive drugs",
"criterion": "systemic treatment with other immunosuppressive drugs",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "in the last 21 days before start of the trial treatment",
"criterion": "time since last systemic treatment",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 21,
"unit": "days"
}
}
]
}
]
},
{
"line": "* Participating in another clinical trial with pharmaceuticals in the last six weeks before start of this trial treatment.",
"criterions": [
{
"exact_snippets": "Participating in another clinical trial with pharmaceuticals in the last six weeks before start of this trial treatment.",
"criterion": "participation in another clinical trial with pharmaceuticals",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 6,
"unit": "weeks"
}
]
}
}
]
}
]
},
{
"line": "* Not able to understand information.",
"criterions": [
{
"exact_snippets": "Not able to understand information.",
"criterion": "ability to understand information",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
},
{
"line": "* Not willing or not able to give written consent to participate in the study.",
"criterions": [
{
"exact_snippets": "Not willing ... to give written consent",
"criterion": "willingness to give written consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "not able to give written consent",
"criterion": "ability to give written consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 80 Years",
"criterions": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Exclusion criteria:",
"criterions": []
},
{
"line": "Patients fulfilling at least one of the following criteria will be excluded from participation in the study:",
"criterions": []
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}